Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
rFSH and HMG are both used to controlled ovarian stimulation for patients submitted to IVF.
However, there is a debate in the literature which one is better to induce ovulation in
patients receiving GnRH antagonist to block premature Luteinizing Hormone (LH) secretion.
The investigators propose a Randomized Clinical Trial (RCT) to investigate the differences
among recombinant FSH and HMG in patients submitted to IVF using GnRH antagonists.